PUBLIC COMPANY
saveNovelMed Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
- phase2Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
- phase2Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
- phase2Study of NM8074 in Adult C3 Glomerulopathy Patients
- phase2Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- phase2Study of NM8074 in Patients with Dermatomyositis (DM)
- phase2Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
- phase2Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that